Skip to main content
. 2020 Jul 22;9(15):e016463. doi: 10.1161/JAHA.120.016463

Table 1.

Baseline Characteristics of the Study Participants

Non‐CKD CKD P value
No. 679 258
Follow‐up, y 8.9 (6–10) 7.6 (4–9) <0.00001
Age, y 65 (57–72) 74 (66–79) <0.00001
Men 555 (82) 217 (84) 0.39
Ethnicity
White 401 (59) 164 (64) 0.6
Black 116 (17) 35 (14)
Asian 80 (12) 27 (11)
Latino 60 (9) 22 (9)
Diabetes mellitus 166 (24) 80 (31) 0.04
Current smoker 152 (22) 32 (12) 0.003
Event rate, %/y 5.4 10.6
Events during follow‐up, No. 284 (42) 180 (70) <0.00001
Time to event, y 8.9 (4.3–9) 5 (1.9–8.9) <0.00001
BMI, kg/m2 27.7 (24.8–31.4) 27.4 (24.9–30.5) 0.37
HDL‐C, mg/dL 43 (36–54) 42 (34–52) 0.1
LDL‐C, mg/dL 99 (82–124) 99 (82–119) 0.32
Total cholesterol, mg/dL 173 (150–199) 168 (146–195) 0.12
Triglycerides, mg/dL 108 (71–166) 119 (81–173) 0.12
Creatinine, mg/dL 0.8 (0.9–1.1) 1.4 (1.2–1.6) <0.00001
eGFR, mL/min per 1.73 m2 80.9 (71.1–93.1) 50.0 (40.1–55.4) <0.00001
CRP, mg/L 2.1 (0.8–4.7) 2.7 (1.1–6.3) 0.004
Systolic blood pressure, mm Hg 130 (118–143) 135 (120–148) 0.001
Diastolic blood pressure, mm Hg 74 (68–80) 72 (68–80) 0.41

Continuous measures are presented as median (interquartile range); categorical measures are presented as n (%) of the column total. BMI indicates body mass index; CKD, chronic kidney disease; CRP, C‐reactive protein; eGFR, estimated glomerular filtration rate; HDL‐C, high‐density lipoprotein cholesterol; and LDL, low‐density lipoprotein cholesterol.